Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Protokinetix Inc (OP: PKTX )

0.0150 -0.0005 (-3.23%)
Streaming Delayed Price Updated: 3:08 PM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 103,800
Open 0.0156
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0155
Today's Range 0.0150 - 0.0170
52wk Range 0.0101 - 0.0300
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nauticus Robotics And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed lower by more than 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Insiders Buying ProtoKinetix And 2 Other Stocks Under $2
The Dow Jones closed lower by over 350 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
Topics Stocks
Exposures US Equities

Performance

YTD
-28.57%
-28.57%
1 Month
-24.24%
-24.24%
3 Month
-2.60%
-2.60%
6 Month
-9.09%
-9.09%
1 Year
-49.15%
-49.15%

More News

Read More
Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
From ProtoKinetix, Incorporated
Via Business Wire
AIM ImmunoTech, InnSuites Hospitality Trust And 2 Other Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
From ProtoKinetix, Incorporated
Via Business Wire
Around $12 Million Bet On Sonim Technologies? 4 Penny Stocks Insiders Are Buying
Via Benzinga
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
From ProtoKinetix, Incorporated
Via Business Wire
4 Penny Stocks Insiders Are Buying
Via Benzinga
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
From ProtoKinetix, Incorporated
Via Business Wire
4 Penny Stocks Insiders Are Buying
Via Benzinga
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
From ProtoKinetix, Incorporated
Via Business Wire
ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes
From ProtoKinetix, Incorporated
Via Business Wire
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
From ProtoKinetix, Incorporated
Via Business Wire
Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration
From ProtoKinetix, Incorporated
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.